28 August 2023
The commencement of construction is scheduled for 2027. The establishment of this facility will greatly accelerate the development of antiviral drugs. According to Anastasia Gladysheva, a senior researcher at the State Scientific Center, Vector is one of the few organizations that possess the necessary level of biological protection. This permits the center to effectively and securely handle highly hazardous viruses.
Most studies involving viral material require a biologically secure building with a minimum security level of Biosafety level -3. Gladysheva states that there is currently no facility anywhere in the world that matches the uniqueness of a virological building with a minimum BSL-3 level of protection, located adjacent to a synchrotron source for research purposes.
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025